Jefferies Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
19,723
-36,477
-65% -$1.78M 0.01% 937
2026
Q1
$2.41M Sell
56,200
-287,333
-84% -$12.4M 0.02% 567
2025
Q4
$15.1M Buy
343,533
+245,909
+252% +$10.2M 0.08% 246
2025
Q3
$4.03M Buy
97,624
+22,624
+30% +$909K 0.02% 435
2025
Q2
$3.31M Buy
+75,000
New +$3M 0.03% 402
2024
Q3
– Sell
-26,000
Closed -$584K – 1540
2024
Q2
$584K Sell
26,000
-160,200
-86% -$3.55M 0.01% 919
2024
Q1
$4.42M Buy
186,200
+26,318
+16% +$585K 0.04% 336
2023
Q4
$3.84M Sell
159,882
-518
-0.3% -$11.3K 0.03% 477
2023
Q3
$3.5M Buy
160,400
+153,400
+2,191% +$3.21M 0.03% 444
2023
Q2
$134K Sell
7,000
-25,500
-78% -$491K ﹤0.01% 1486
2023
Q1
$631K Buy
+32,500
New +$566K 0.01% 1033

Other funds holding EXEL

Jefferies Financial Group's EXEL Position: Q2 2026 in Review

Jefferies Financial Group reduced its Exelixis (EXEL) stake by 65% in Q2 2026, selling an estimated $1.78M and leaving 19,723 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #937.

Jefferies Financial Group first reported a position in EXEL in Q1 2023 and has held it in 11 quarters since. The position peaked at $15.1M in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Jefferies Financial Group held 19,723 shares of Exelixis worth $1.07M as of Q2 2026.
  • Jefferies Financial Group sold 36,477 Exelixis shares in Q2 2026, an estimated $1.78M.
  • Exelixis made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #937 holding.
  • Jefferies Financial Group first reported a position in Exelixis in Q1 2023 and has held it in 11 quarters since.
  • Jefferies Financial Group's Exelixis position peaked at $15.1M in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.